arrow
W

Wilson Lam

Princess Margaret Cancer Centre
H指数:22
被引数:1,739

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Effect of Smoking and Pre-Allogeneic Hematopoietic Cell Transplant Pulmonary Comorbidity on the Incidence of Lung Graft-Versus-Host Disease and Post-Transplant Outcomes

吸烟和异基因造血干细胞移植前合并症对肺移植物抗宿主病发生率和移植后结局的影响

Cancers
IF4.4
2026-01-180
OAAI
Risk prediction for surgery on adults with congenital heart disease: non-procedural clinical and social factors predominate

成人先天性心脏病手术的风险预测:非程序性临床和社会因素占主导地位

2025-11-080
PRE
Herpes zoster frequency and adjuvanted recombinant zoster vaccination after allogeneic hematopoietic cell transplantation

带状疱疹频率及异基因造血细胞移植后的佐剂重组带状疱疹疫苗接种

2025-10-280
PRE
Size does not always matter: limited impact of donor-recipient weight difference on outcomes of adult allogeneic peripheral blood stem cell hematopoietic cell transplantation

体重差异并不总是重要:供受体体重差异对成人同种异基因外周血干细胞造血细胞移植结局的有限影响

2025-10-060
PRE
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis

能否超越骨髓清除性预处理(MAC)?一项在年龄小于65岁的异基因造血细胞移植患者中使用ATG-PTCy-CSA预防GVHD的MAC与减低强度预处理(RIC)的比较研究

2025-09-180
PRE
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation

异基因造血干细胞移植后,移植物抗宿主病预防措施对第二原发恶性肿瘤的影响

2025-07-190
PRE
Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant With Graft Failure and Relapse Risk in Hematological Malignancies

异基因造血细胞移植后环孢素暴露与血液系统恶性肿瘤中移植物失败和复发风险的关系

2025-06-110
PRE
Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challenges

高危患者接受异基因干细胞移植时的长期住院:应对医疗保健挑战的呼吁

2025-06-030
PRE
Tolerability and Efficacy of Post-Transplant Cyclophosphamide in Older Adults Undergoing Matched Sibling Donor Allogeneic Transplantation: A Retrospective Analysis

移植后环磷酰胺在匹配同胞供者异基因移植老年患者中的耐受性与疗效:一项回顾性分析

BLOOD
IF23.1
2024-11-050
PRE
Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

在AML患者中,对于65岁以下人群,采用抗胸腺细胞球蛋白与移植后环磷酰胺联合作为GVHD预防措施时,可改善预后。

BLOOD
IF23.1
2024-11-050
PRE
Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

相对于减低强度预处理,在65岁以下MDS患者中使用抗胸腺细胞球蛋白和移植后环磷酰胺联合方案作为GvHD预防措施时,观察到更强的生存优势。

BLOOD
IF23.1
2024-11-050
PRE
Strength to Endure: Superiority of MAC over RIC in Patients < 65 Years Undergoing Stem Cell Transplantation Using ATG-Ptcy-CSA for Gvhd Prophylaxis

耐受性优势:在年龄小于65岁、使用ATG-Ptcy-CSA进行GvHD预防的干细胞移植患者中,MAC方案优于RIC方案

BLOOD
IF23.1
2024-11-050
PRE
Haploidentical and Mismatched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Cohort Study

haploidentical and Mismatched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis: 一项回顾性队列研究

BLOOD
IF23.1
2024-11-050
PRE
The Use of Post-Transplant Cyclophosphamide Leads to Increased Cardiac Complications without Affecting Survival in Haploidentical Stem Cell Transplantation

异基因干细胞移植中使用移植后环磷酰胺会导致心脏并发症增加,但不影响生存率。

BLOOD
IF23.1
2024-11-050
PRE
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study

Treosulfan与基于白消安的异基因造血干细胞移植治疗骨髓增生异常综合征: 一项单中心回顾性倾向评分匹配队列研究

2024-07-010
PRE
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation

移植前Blinatumomab可改善接受异基因造血细胞移植的b细胞急性淋巴细胞白血病患者的预后

2024-05-016
PRE
Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

基于抗胸腺细胞球蛋白-环磷酰胺-环孢素和基于抗胸腺细胞球蛋白的移植后预防10/10 HLA匹配的无关供者异基因造血细胞移植的结果

2024-05-012
PRE